Denis Chem Lab Ltd
BSE:537536
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
D
|
Denis Chem Lab Ltd
BSE:537536
|
1.1B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
284.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.9B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Denis Chem Lab Ltd
Glance View
Denis Chem Lab Ltd. engages in the manufacture and sale of transfusion solution in bottles. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2014-02-21. The firm is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. The company offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. The company manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The firm also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Denis Chem Lab Ltd is 4.8%, which is below its 3-year median of 5.5%.
Over the last 3 years, Denis Chem Lab Ltd’s Net Margin has increased from 4.8% to 4.8%. During this period, it reached a low of 4.7% on Mar 31, 2025 and a high of 6.8% on Sep 30, 2024.
